← All organizations
Highest phase reached
Phase 4
First clinical trial
May 1, 2001First marketed drug
Dec 17, 2004First NDA
Dec 17, 2004Last known activity
Dec 5, 2011
Acquired by Bausch Health Companies on Feb 13, 2012
Timeline
1990s
- Jul 1, 1997
Eyetech Pharmaceuticals— Founded
2000s
- Dec 17, 2004
pegaptanib— NDA Organization
2010s
- Feb 13, 2012
Bausch Health Companies— Acquired By
Drugs by trial phase (2 distinct, 15 trials)
Phase 4 (2 own, 0 via acquisition)
Indications
Approved for
Marketed drugs (1)
Recent trials (15)
- NCT01487044CollaboratorN/ADec 5, 2011
- NCT00358423CollaboratorPhase 1/Phase 2Jul 1, 2006
- NCT00346983CollaboratorPhase 1/Phase 2Jun 1, 2006
- NCT00354445Lead sponsorPhase 4Jun 1, 2006
- NCT00312351Lead sponsorPhase 4Apr 1, 2006
- NCT00295828CollaboratorPhase 1Jan 31, 2006
- NCT00406107CollaboratorPhase 4Jan 1, 2006
- NCT00134667Lead sponsorPhase 4Mar 1, 2005
- NCT00088192Lead sponsorN/AJul 1, 2004
- NCT00088283Lead sponsorPhase 2May 1, 2004
- NCT00087763Lead sponsorPhase 2Mar 1, 2004
- NCT00215670Lead sponsorPhase 2/Phase 3Nov 1, 2002
- NCT00040313Lead sponsorPhase 2Oct 1, 2002
- NCT00021736Lead sponsorPhase 2/Phase 3Jul 1, 2001
- NCT00321997Lead sponsorPhase 2/Phase 3May 1, 2001
Details
- Founded
- New York, NY, US Jul 1, 1997
- First NDA
- Dec 17, 2004
- Last known activity
- Dec 5, 2011
Designations held
- Priority review
Notes
Acquired by Valeant